Expression of COPZ1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

COPZ1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 107.8

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

132.2

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	240.5
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	227.3
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	222.1
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	218.4
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	209.2
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	207.0
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	195.7
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	191.5
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	190.1
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	189.1
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	188.7
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	187.7
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	183.0
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	179.8
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	179.1
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	174.2
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	173.6
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	173.1
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	169.9
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	169.4
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	164.4
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	163.9
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	162.7
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	161.7
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	158.7
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	158.5
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	158.0
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	157.2
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	156.3
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	155.5
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	153.9
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	153.2
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	150.9
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	150.7
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	150.3
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	149.6
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	148.7
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	147.6
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	146.4
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	145.7
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	144.6
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	144.5
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	144.0
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	143.7
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	142.8
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	142.3
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	142.2
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	142.1
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	141.6
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	140.7
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	140.2
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	140.0
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	138.2
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	137.8
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	137.1
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	137.0
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	136.0
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	135.0
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	134.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	134.6
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	133.9
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	133.1
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	131.9
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	130.5
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	130.5
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	130.2
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	129.7
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	128.9
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	128.9
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	128.8
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	128.1
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	127.7
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	127.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	127.3
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	127.1
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	126.3
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	126.2
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	126.0
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	125.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	125.1
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	124.4
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	123.7
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	123.2
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	122.2
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	121.8
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	120.9
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	119.7
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	119.7
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	118.3
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	118.2
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	117.8
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	117.0
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	116.9
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	116.8
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	116.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	115.7
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	115.5
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	115.3
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	115.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	114.9
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	113.5
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	112.4
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	111.8
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	111.7
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	111.5
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	111.4
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	109.8
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	109.7
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	108.2
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	108.0
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	107.6
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	106.8
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	106.4
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	105.6
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	104.7
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	104.4
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	104.2
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	104.1
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	104.1
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	104.0
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	103.8
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	103.1
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	102.5
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	97.8
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	97.5
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	95.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	95.2
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	93.2
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	90.2
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	88.8
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	87.1
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	86.9
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	86.3
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	84.0
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	83.6
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	69.8
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	69.2
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	66.9
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	66.1
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	59.2
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	49.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

COPZ1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 31.81

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

28.4

Number of samples

Samples

Sample	Description	TPM
AK156	N, NA, stage:NA, dead, 330 days	58.8
AK002	N, NA, stage:NA, dead, 570 days	53.9
AK185	N, NA, stage:NA, alive, 330 days	39.6
AK051	N, NA, stage:NA, dead, 360 days	37.2
AK195	N, NA, stage:NA, dead, 390 days	37.1
AK153	N, NA, stage:NA, dead, 240 days	35.2
AK124	N, NA, stage:NA, alive, 1920 days	33.7
AK003	N, NA, stage:NA, dead, 600 days	33.5
AK142	N, NA, stage:NA, alive, 90 days	33.3
AK071	N, NA, stage:NA, dead, 540 days	32.4
AK074	N, NA, stage:NA, alive, 300 days	32.2
AK227	N, NA, stage:NA, alive, 300 days	32.2
AK183	N, NA, stage:NA, alive, 360 days	32.0
AK236	N, NA, stage:NA, dead, 360 days	31.7
AK139	N, NA, stage:NA, dead, 270 days	31.3
AK055	N, NA, stage:NA, dead, 240 days	31.3
AK213	N, NA, stage:NA, alive, 2010 days	30.7
AK098	N, NA, stage:NA, dead, 660 days	30.2
AK079	N, NA, stage:NA, dead, 210 days	30.0
AK218	N, NA, stage:NA, dead, 180 days	30.0
AK123	N, NA, stage:NA, dead, 180 days	29.9
AK149	N, NA, stage:NA, dead, 420 days	29.9
AK030	N, NA, stage:NA, dead, 120 days	29.2
AK066	N, NA, stage:NA, alive, 960 days	29.2
AK081	N, NA, stage:NA, dead, 180 days	29.0
AK188	N, NA, stage:NA, alive, 420 days	28.6
AK231	N, NA, stage:NA, dead, 240 days	28.0
AK099	N, NA, stage:NA, dead, 420 days	27.9
AK041	N, NA, stage:NA, alive, 810 days	27.7
AK165	N, NA, stage:NA, alive, 360 days	27.6
AK133	N, NA, stage:NA, dead, 360 days	27.4
AK178	N, NA, stage:NA, dead, 240 days	27.2
AK035	N, NA, stage:NA, dead, 210 days	27.1
AK049	N, NA, stage:NA, dead, 180 days	26.7
AK068	N, NA, stage:NA, alive, 360 days	26.4
AK100	N, NA, stage:NA, alive, 960 days	25.8
AK088	N, NA, stage:NA, dead, 360 days	25.7
AK199	N, NA, stage:NA, alive, 1860 days	25.2
AK216	N, NA, stage:NA, dead, 360 days	25.1
AK005	N, NA, stage:NA, dead, 240 days	25.0
AK173	N, NA, stage:NA, dead, 180 days	24.9
AK072	N, NA, stage:NA, dead, 150 days	24.9
AK076	N, NA, stage:NA, alive, 660 days	24.5
AK103	N, NA, stage:NA, alive, 1320 days	24.1
AK117	N, NA, stage:NA, dead, 210 days	24.0
AK089	N, NA, stage:NA, dead, 330 days	23.7
AK158	N, NA, stage:NA, dead, 360 days	23.6
AK226	N, NA, stage:NA, dead, 360 days	23.5
AK053	N, NA, stage:NA, dead, 300 days	23.0
AK043	N, NA, stage:NA, alive, 660 days	22.5
AK205	N, NA, stage:NA, dead, 120 days	22.4
AK085	N, NA, stage:NA, alive, 660 days	22.1
AK134	N, NA, stage:NA, dead, 360 days	22.0
AK091	N, NA, stage:NA, dead, 210 days	21.7
AK167	N, NA, stage:NA, dead, 180 days	19.3
AK015	N, NA, stage:NA, alive, 720 days	17.7
AK102	N, NA, stage:NA, alive, 1740 days	14.6
AK006	N, NA, stage:NA, dead, 360 days	14.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0208980003	Tumor	0.6
CPT0207090003	Tumor	0.5
CPT0125570003	Tumor	0.4
CPT0093450003	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0218330004	Tumor	0.4
CPT0078580003	Tumor	0.4
CPT0089150003	Tumor	0.3
CPT0217060003	Tumor	0.3
CPT0186100003	Tumor	0.3
CPT0216920008	Tumor	0.3
CPT0228220003	Tumor	0.3
CPT0189850004	Tumor	0.3
CPT0161730003	Tumor	0.3
CPT0087570003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0218770003	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0182500003	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0218830004	Tumor	0.2
CPT0190360004	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0127480003	Tumor	0.2
CPT0093510003	Tumor	0.2
CPT0206000004	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0217000004	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0206780003	Tumor	0.1
CPT0167970003	Tumor	0.1
CPT0204380003	Normal	0.1
CPT0217710008	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0217880003	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0064890003	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0093360003	Tumor	0.1
CPT0196850003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0224390004	Tumor	0.1
CPT0162020003	Tumor	0.1
CPT0225760003	Tumor	0.0
CPT0209440003	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0175060003	Tumor	0.0
CPT0199770003	Tumor	0.0
CPT0217190003	Tumor	0.0
CPT0162100003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0206560003	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0221180003	Tumor	0.0
CPT0206330003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0125510003	Tumor	0.0
CPT0224540004	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0087730003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0171580008	Tumor	0.0
CPT0224330003	Tumor	0.0
CPT0206230003	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0204390003	Normal	-0.1
CPT0204360003	Normal	-0.1
CPT0204340003	Normal	-0.1
CPT0217430008	Tumor	-0.1
CPT0205670004	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0087950003	Tumor	-0.2
CPT0218960004	Tumor	-0.2
CPT0219080004	Tumor	-0.2
CPT0204370003	Normal	-0.2
CPT0204400003	Normal	-0.2
CPT0201710003	Tumor	-0.3
CPT0204420003	Normal	-0.3
CPT0189460003	Tumor	-0.3
CPT0092440003	Tumor	-0.3
CPT0206110003	Tumor	-0.3
CPT0104330003	Tumor	-0.3
CPT0168380003	Tumor	-0.3
CPT0104220003	Tumor	-0.3
CPT0162140003	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0205890003	Tumor	-0.3
CPT0204330003	Normal	-0.3
CPT0189570004	Tumor	-0.4
CPT0190240004	Tumor	-0.4
CPT0204350003	Normal	-0.5
CPT0204410003	Normal	-0.5
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis